Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-Cell malignancies: A report from the children's oncology group

Authors

S. L. Berg
S. M. Blaney
M. Devidas
T. A. Lampkin
A. Murgo

Document Type

Journal Article

Publication Date

2005

Journal

Journal of Clinical Oncology

Volume

23

Issue

15

Inclusive Pages

3376-3382

APA Citation

Berg, S., Blaney, S., Devidas, M., Lampkin, T., & Murgo, A. (2005). Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-Cell malignancies: A report from the children's oncology group. Journal of Clinical Oncology, 23 (15). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/4251